García-Alfonso, Pilar http://orcid.org/0000-0002-4373-9978
Vera, Ruth
Aranda, Enrique
Élez, Elena
Rivera, Fernando
Funding for this research was provided by:
Servier
Universidad Complutense de Madrid
Article History
Received: 13 September 2023
Accepted: 5 December 2023
First Online: 27 February 2024
Declarations
:
: PG-A received honoraria/consultation fees for speaker and consultancy/advisory roles from Amgen, Bayer, Bristol, Merck Serono, MSD, Lilly, Roche, Sanofi, Servier, and Pierre Fabre. RV received honoraria from/acted in an advisory role for Roche, Sanofi, MSD, Merck, Amgen, Novartis, Pierre Fabre, Lilly, and Servier; funding for educational/research programs from Roche, Lilly, and MSD; as well as payment of travel/accommodation expenses from Roche, Merck, Sanofi, Pierre Fabre, Servier, and MSD. EA received honoraria for an advisory role from Amgen, Bayer, Bristol Myers Squibb, Merck, Roche, Sanofi, and Servier; and received research funding from Roche. EE received honoraria from Amgen, Bayer, Hoffman La-Roche, Merck Serono, MSD, Novartis, Organon, Pierre Fabre, Pfizer, Sanofi, Seagen, Servier, and Takeda. FR was a consultant/advisor for Roche, Merck-Serono, Amgen, MSD, BMS, Lilly, Celgene, Sanofi-Aventis, Servier, Astra-Zeneca, Bayer, and Astellas; received research funding from Roche, Merck-Serono, Amgen, MSD, Lilly, Celgene, Sanofi-Aventis, Servier, Bayer; participated as a speaker for Roche, Merck-Serono, Amgen, MSD, BMS, Lilly, Celgene, Sanofi-Aventis, Servier, Bayer; and received grant support from Amgen.
: The manuscript does not contain clinical studies or patient data. No patients have participated.
: Informed consent were not necessary.